AGILENT TECHNOLOGIES INC (A) Fundamental Analysis & Valuation

NYSE:A • US00846U1016

Current stock price

111.3 USD
-0.45 (-0.4%)
At close:
111.3 USD
0 (0%)
After Hours:

This A fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. A Profitability Analysis

1.1 Basic Checks

  • In the past year A was profitable.
  • In the past year A had a positive cash flow from operations.
  • In the past 5 years A has always been profitable.
  • Each year in the past 5 years A had a positive operating cash flow.
A Yearly Net Income VS EBIT VS OCF VS FCFA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • With an excellent Return On Assets value of 10.07%, A belongs to the best of the industry, outperforming 91.23% of the companies in the same industry.
  • A's Return On Equity of 18.67% is amongst the best of the industry. A outperforms 91.23% of its industry peers.
  • A has a Return On Invested Capital of 12.40%. This is amongst the best in the industry. A outperforms 89.47% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for A is in line with the industry average of 11.85%.
Industry RankSector Rank
ROA 10.07%
ROE 18.67%
ROIC 12.4%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
A Yearly ROA, ROE, ROICA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • A has a better Profit Margin (18.26%) than 87.72% of its industry peers.
  • In the last couple of years the Profit Margin of A has grown nicely.
  • A has a Operating Margin of 21.76%. This is amongst the best in the industry. A outperforms 91.23% of its industry peers.
  • A's Operating Margin has improved in the last couple of years.
  • The Gross Margin of A (52.53%) is better than 64.91% of its industry peers.
  • In the last couple of years the Gross Margin of A has remained more or less at the same level.
Industry RankSector Rank
OM 21.76%
PM (TTM) 18.26%
GM 52.53%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
A Yearly Profit, Operating, Gross MarginsA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. A Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), A is creating some value.
  • A has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, A has less shares outstanding
  • A has a better debt/assets ratio than last year.
A Yearly Shares OutstandingA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
A Yearly Total Debt VS Total AssetsA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • A has an Altman-Z score of 4.54. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.54, A belongs to the best of the industry, outperforming 85.96% of the companies in the same industry.
  • The Debt to FCF ratio of A is 3.38, which is a good value as it means it would take A, 3.38 years of fcf income to pay off all of its debts.
  • A has a better Debt to FCF ratio (3.38) than 80.70% of its industry peers.
  • A has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • A has a Debt to Equity ratio of 0.49. This is in the lower half of the industry: A underperforms 63.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.38
Altman-Z 4.54
ROIC/WACC1.15
WACC10.74%
A Yearly LT Debt VS Equity VS FCFA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 2.07 indicates that A has no problem at all paying its short term obligations.
  • A has a Current ratio of 2.07. This is in the lower half of the industry: A underperforms 63.16% of its industry peers.
  • A has a Quick Ratio of 1.59. This is a normal value and indicates that A is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.59, A is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
  • The current and quick ratio evaluation for A is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.59
A Yearly Current Assets VS Current LiabilitesA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

5

3. A Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.03% over the past year.
  • The Earnings Per Share has been growing by 11.21% on average over the past years. This is quite good.
  • Looking at the last year, A shows a quite strong growth in Revenue. The Revenue has grown by 8.14% in the last year.
  • Measured over the past years, A shows a small growth in Revenue. The Revenue has been growing by 5.41% on average per year.
EPS 1Y (TTM)6.03%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%3.82%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%6.96%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.72% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.00% on average over the next years.
EPS Next Y8.97%
EPS Next 2Y9.5%
EPS Next 3Y10.1%
EPS Next 5Y9.72%
Revenue Next Year6.79%
Revenue Next 2Y6.45%
Revenue Next 3Y6.41%
Revenue Next 5Y6%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
A Yearly Revenue VS EstimatesA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
A Yearly EPS VS EstimatesA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

5

4. A Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 19.77, which indicates a rather expensive current valuation of A.
  • Compared to the rest of the industry, the Price/Earnings ratio of A indicates a rather cheap valuation: A is cheaper than 84.21% of the companies listed in the same industry.
  • A is valuated rather cheaply when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 16.63, the valuation of A can be described as correct.
  • Based on the Price/Forward Earnings ratio, A is valued cheaply inside the industry as 82.46% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of A to the average of the S&P500 Index (23.28), we can say A is valued slightly cheaper.
Industry RankSector Rank
PE 19.77
Fwd PE 16.63
A Price Earnings VS Forward Price EarningsA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, A is valued a bit cheaper than 77.19% of the companies in the same industry.
  • 66.67% of the companies in the same industry are more expensive than A, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.69
EV/EBITDA 18.07
A Per share dataA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates A does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of A may justify a higher PE ratio.
PEG (NY)2.2
PEG (5Y)1.76
EPS Next 2Y9.5%
EPS Next 3Y10.1%

5

5. A Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.86%, A is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.11, A pays a better dividend. On top of this A pays more dividend than 100.00% of the companies listed in the same industry.
  • With a Dividend Yield of 0.86, A pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.86%

5.2 History

  • On average, the dividend of A grows each year by 6.57%, which is quite nice.
  • A has paid a dividend for at least 10 years, which is a reliable track record.
  • A has decreased its dividend recently.
Dividend Growth(5Y)6.57%
Div Incr Years1
Div Non Decr Years1
A Yearly Dividends per shareA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 21.94% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
  • A's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.94%
EPS Next 2Y9.5%
EPS Next 3Y10.1%
A Yearly Income VS Free CF VS DividendA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
A Dividend Payout.A Dividend Payout, showing the Payout Ratio.A Dividend Payout.PayoutRetained Earnings

A Fundamentals: All Metrics, Ratios and Statistics

AGILENT TECHNOLOGIES INC

NYSE:A (3/20/2026, 8:04:00 PM)

After market: 111.3 0 (0%)

111.3

-0.45 (-0.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-25
Earnings (Next)05-26
Inst Owners92%
Inst Owner Change-0.33%
Ins Owners0.16%
Ins Owner Change3.09%
Market Cap31.46B
Revenue(TTM)7.07B
Net Income(TTM)1.29B
Analysts78.62
Price Target171.65 (54.22%)
Short Float %1.62%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 0.86%
Yearly Dividend0.99
Dividend Growth(5Y)6.57%
DP21.94%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-31
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.09%
Min EPS beat(2)-2.58%
Max EPS beat(2)-1.6%
EPS beat(4)1
Avg EPS beat(4)-1.06%
Min EPS beat(4)-2.58%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.21%
EPS beat(12)8
Avg EPS beat(12)0.61%
EPS beat(16)11
Avg EPS beat(16)1.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-2.44%
Max Revenue beat(2)-0.43%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)2.3%
Revenue beat(8)2
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.34%
Revenue beat(16)7
Avg Revenue beat(16)0.07%
PT rev (1m)0%
PT rev (3m)0.67%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)0.54%
EPS NY rev (1m)0.46%
EPS NY rev (3m)0.03%
Revenue NQ rev (1m)1.89%
Revenue NQ rev (3m)1.83%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 19.77
Fwd PE 16.63
P/S 4.45
P/FCF 31.69
P/OCF 22.54
P/B 4.55
P/tB 15.75
EV/EBITDA 18.07
EPS(TTM)5.63
EY5.06%
EPS(NY)6.69
Fwd EY6.01%
FCF(TTM)3.51
FCFY3.16%
OCF(TTM)4.94
OCFY4.44%
SpS24.99
BVpS24.44
TBVpS7.07
PEG (NY)2.2
PEG (5Y)1.76
Graham Number55.64
Profitability
Industry RankSector Rank
ROA 10.07%
ROE 18.67%
ROCE 14.53%
ROIC 12.4%
ROICexc 14.78%
ROICexgc 32.01%
OM 21.76%
PM (TTM) 18.26%
GM 52.53%
FCFM 14.06%
ROA(3y)10.88%
ROA(5y)11.17%
ROE(3y)20.8%
ROE(5y)21.7%
ROIC(3y)13.47%
ROIC(5y)13.97%
ROICexc(3y)16.03%
ROICexc(5y)16.51%
ROICexgc(3y)38.11%
ROICexgc(5y)42.31%
ROCE(3y)15.36%
ROCE(5y)15.95%
ROICexgc growth 3Y-8.87%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y-4.92%
ROICexc growth 5Y7.55%
OM growth 3Y-1.66%
OM growth 5Y6.93%
PM growth 3Y0.8%
PM growth 5Y6.85%
GM growth 3Y-1%
GM growth 5Y-0.15%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.38
Debt/EBITDA 1.84
Cap/Depr 142.4%
Cap/Sales 5.7%
Interest Coverage 15.53
Cash Conversion 76.7%
Profit Quality 76.98%
Current Ratio 2.07
Quick Ratio 1.59
Altman-Z 4.54
F-Score6
WACC10.74%
ROIC/WACC1.15
Cap/Depr(3y)132.79%
Cap/Depr(5y)109.81%
Cap/Sales(3y)5.34%
Cap/Sales(5y)4.65%
Profit Quality(3y)104.6%
Profit Quality(5y)100.47%
High Growth Momentum
Growth
EPS 1Y (TTM)6.03%
EPS 3Y2.31%
EPS 5Y11.21%
EPS Q2Q%3.82%
EPS Next Y8.97%
EPS Next 2Y9.5%
EPS Next 3Y10.1%
EPS Next 5Y9.72%
Revenue 1Y (TTM)8.14%
Revenue growth 3Y0.48%
Revenue growth 5Y5.41%
Sales Q2Q%6.96%
Revenue Next Year6.79%
Revenue Next 2Y6.45%
Revenue Next 3Y6.41%
Revenue Next 5Y6%
EBIT growth 1Y-1.09%
EBIT growth 3Y-1.19%
EBIT growth 5Y12.72%
EBIT Next Year27.75%
EBIT Next 3Y14.3%
EBIT Next 5Y11.62%
FCF growth 1Y-39.78%
FCF growth 3Y4.11%
FCF growth 5Y7.51%
OCF growth 1Y-28.81%
OCF growth 3Y5.92%
OCF growth 5Y11.1%

AGILENT TECHNOLOGIES INC / A Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AGILENT TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 7 / 10 to A.


Can you provide the valuation status for AGILENT TECHNOLOGIES INC?

ChartMill assigns a valuation rating of 5 / 10 to AGILENT TECHNOLOGIES INC (A). This can be considered as Fairly Valued.


Can you provide the profitability details for AGILENT TECHNOLOGIES INC?

AGILENT TECHNOLOGIES INC (A) has a profitability rating of 8 / 10.


What is the valuation of AGILENT TECHNOLOGIES INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AGILENT TECHNOLOGIES INC (A) is 19.77 and the Price/Book (PB) ratio is 4.55.


Can you provide the dividend sustainability for A stock?

The dividend rating of AGILENT TECHNOLOGIES INC (A) is 5 / 10 and the dividend payout ratio is 21.94%.